首页 > microbix > microbix/Rubella BR2S/1mg/EL-05-15-001

提醒：代购产品，无质量问题不接受退换货，下单前请仔细核对信息。下单后请及时联系客服核对商品价格，订单生效后再付款。

microbix/Rubella BR2S/1mg/EL-05-15-001

价格：

登录查看

自营商城

解放采购

正品保障

及时交付

厂家直采

一站服务

货号：

EL-05-15-001

品牌：

microbix

会员服务：

尊享会员价

贵宾专线

运费优惠

闪电退款

福利优惠

上门换新

友情提示

以上价格仅为参考，请联系客服询价。

免费咨询热线

4000-520-616

产品说明

MORE DETAILSDescriptionQuality AssuranceInformation Sheet Rubella causes a mild rash illness of children and adults known as German measles. There is often pharyngitis and enlargement of the cervical lymph nodes. Infection often occurs during childhood with many infections being asymptomatic and complications being rare. However, infection of women in the first 16 weeks of pregnancy can lead to congenital defects developing in the foetus such as cataracts, nerve deafness and cardiac abnormalities. Antibody in women of childbearing age protects the foetus from being infected and thereby prevents congenital abnormalities from developing. Rubella virus is classified as a toga virus. It is immunologically distinct from other known viruses. The virus particle is spherical with a diameter of 60 - 70 nm and contains a single strand of RNA in a nucleocapsid surrounded by a lipid envelope. It has three structural proteins; E1 and E2, which are associated with the viral envelope and C which forms the nucleocapsid with RNA. E1 is reactive with IgM and IgG antibodies and is the antigen responsible for haemagglutination activity. E2 and C induce IgG antibodies but E1 is most important to antibody testing.View the Sample Sample Product Information Sheet.Inactivation & Safety — Each lot of Rubella antigen is inactivated using ultraviolet radtiation and this inactivation verified using a sensitive tissue culture based infectivity assay. Microbix’ proprietary inactivation strategy is the best in the industry, and provides the highest level of safety you will find.Applications — Missing content.Ordering Information — Limited to 10 units per online order. For any larger orders, contact us through our link at the bottom of the page. Each antigen lot is tested for potency using ELISA, and compared to a reference antigen. This ensures the amount of viral protein in each batch is consistent. The total protein concentration reported includes both viral and non-viral proteins, with the ratio dependent on the purity of the antigen. View our Quality Policy and ISO Certification.

Microbix生物系统

加拿大Microbix Biosystems www.microbix.com
加拿大Microbix Biosystems成立于1988年，是世界顶尖的生物技术公司，其流感疫苗生产技术具有世界一流水平。
Microbix专门从事专有生物技术的开发，这导致了三个领域产品线的开发；生物治疗剂，疫苗和非治疗性生物制剂。公司根据潜在的近期市场机会选择开发产品，以在高利润业务中提供高于平均水平的回报。在进入市场之前，Microbix流水线中的产品通常具有有限的监管壁垒或根本没有监管要求。